Autoantibody profiling using microarray identifies biomarkers associated with chemoimmunotherapy efficacy and immune-related adverse events in lung cancer patientsZuo Wang, Xiaobo Yu, Xiaomei Zhang et al.|Clinical and Experimental Medicine|2025Cited by 3
Precision medicine research on chemo-immunotherapy combination treatment for locally advanced or metastatic non-small cell lung cancer based on deep plasma proteomics.Qiuchi Chen, Xiaorong Dong, Qiaoyun Tan et al.|Journal of Clinical Oncology|2025Cited by 0